Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases.
Karagianni K, Bibi A, Madé A, Acharya S, Parkkonen M, Barbalata T, Srivastava PK, de Gonzalo-Calvo D, Emanueli C, Martelli F, Devaux Y, Dafou D, Nossent AY; EU-CardioRNA COST Action CA17129.
Karagianni K, et al. Among authors: bibi a.
Mol Ther Nucleic Acids. 2023 Dec 5;35(1):102085. doi: 10.1016/j.omtn.2023.102085. eCollection 2024 Mar 12.
Mol Ther Nucleic Acids. 2023.
PMID: 38192612
Free PMC article.
Review.